OD-07656

N/A

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameOD-07656
Drug Alias NameOD-07656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase RIPK2 inhibitors
TargetsSerine/threonine-protein kinase RIPK2
Therapy Area/IndicationsHereditary Autoinflammatory DiseasesCrohn DiseaseInflammatory Bowel Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUkraine +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOdyssey Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHereditary Autoinflammatory DiseasesCrohn DiseaseInflammatory Bowel Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A